These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32214385)

  • 1. Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities.
    Foolad F; Khodagholi F; Nabavi SM; Javan M
    PLoS One; 2020; 15(3):e0230691. PubMed ID: 32214385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuins and Metabolism Biomarkers in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: a Correlation Study with Clinical Outcomes and Cognitive Impairments.
    Foolad F; Samadi-Bahrami Z; Khodagholi F; Nabavi SM; Moore GRW; Javan M
    Mol Neurobiol; 2024 Jun; 61(6):3442-3460. PubMed ID: 37995076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in Chinese neuromyelitis optica.
    Zhang N; Li YJ; Fu Y; Shao JH; Luo LL; Yang L; Shi FD; Liu Y
    Mult Scler; 2015 Dec; 21(14):1839-46. PubMed ID: 25828756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study.
    Duan Y; Liu Y; Liang P; Jia X; Ye J; Dong H; Li K
    Acta Radiol; 2014 Jun; 55(5):589-93. PubMed ID: 23966367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive functions in neuromyelitis optica.
    Blanc F; Zéphir H; Lebrun C; Labauge P; Castelnovo G; Fleury M; Sellal F; Tranchant C; Dujardin K; Vermersch P; de Seze J
    Arch Neurol; 2008 Jan; 65(1):84-8. PubMed ID: 18195143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
    Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y
    BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
    Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
    Blanc F; Noblet V; Jung B; Rousseau F; Renard F; Bourre B; Longato N; Cremel N; Di Bitonto L; Kleitz C; Collongues N; Foucher J; Kremer S; Armspach JP; de Seze J
    PLoS One; 2012; 7(4):e33878. PubMed ID: 22509264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
    Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C
    J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
    Altintas A; Karabudak R; Balci BP; Terzi M; Soysal A; Saip S; Tuncer Kurne A; Uygunoglu U; Nalbantoglu M; Gozubatik Celik G; Isik N; Celik Y; Gokcay F; Duman T; Boz C; Yucesan C; Mangan MS; Celebisoy N; Diker S; Colpak Isikay I; Kansu T; Siva A
    Neurologist; 2015 Oct; 20(4):61-6. PubMed ID: 26468870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomography in neuromyelitis optica.
    de Seze J; Blanc F; Jeanjean L; Zéphir H; Labauge P; Bouyon M; Ballonzoli L; Castelnovo G; Fleury M; Defoort S; Vermersch P; Speeg C
    Arch Neurol; 2008 Jul; 65(7):920-3. PubMed ID: 18625858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain abnormalities in neuromyelitis optica.
    Pittock SJ; Lennon VA; Krecke K; Wingerchuk DM; Lucchinetti CF; Weinshenker BG
    Arch Neurol; 2006 Mar; 63(3):390-6. PubMed ID: 16533966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.
    Zhang Y; Zhang X; Liu D; Wang H; Pan S; Wang D; Chen X
    Neurol Sci; 2016 Nov; 37(11):1823-1829. PubMed ID: 27450097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].
    Bi CF; Qian HR; Peng LJ; Mao LL; Huang X; Xia DY; Lei X; Qi XK
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):460-5. PubMed ID: 27256609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment and whole brain diffusion in patients with neuromyelitis optica after acute relapse.
    He D; Wu Q; Chen X; Zhao D; Gong Q; Zhou H
    Brain Cogn; 2011 Oct; 77(1):80-8. PubMed ID: 21723024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN).
    Chen X; Zeng C; Luo T; Ouyang Y; Lv F; Rumzan R; Wang Z; Li Q; Wang J; Hou H; Huang F; Li Y
    Eur J Radiol; 2012 Apr; 81(4):e633-9. PubMed ID: 22280874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased SIRT1 mRNA expression in peripheral blood mononuclear cells from patients with neuromyelitis optica spectrum disorders.
    Zhang L; Xue Y; Yuan C; Du X; Wang X; Guo L; Li B
    Acta Neurol Belg; 2023 Dec; 123(6):2287-2294. PubMed ID: 37294424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural MRI substrates of cognitive impairment in neuromyelitis optica.
    Liu Y; Fu Y; Schoonheim MM; Zhang N; Fan M; Su L; Shen Y; Yan Y; Yang L; Wang Q; Zhang N; Yu C; Barkhof F; Shi FD
    Neurology; 2015 Oct; 85(17):1491-9. PubMed ID: 26423432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive and psychiatric comorbidities in neuromyelitis optica.
    Moore P; Methley A; Pollard C; Mutch K; Hamid S; Elsone L; Jacob A
    J Neurol Sci; 2016 Jan; 360():4-9. PubMed ID: 26723962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.